[HTML][HTML] Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
…, M Abbasi, M Abbasifard, M Abbasi-Kangevari… - The lancet, 2020 - thelancet.com
Background In an era of shifting global agendas and expanded emphasis on non-communicable
diseases and injuries along with communicable diseases, sound evidence on trends …
diseases and injuries along with communicable diseases, sound evidence on trends …
[HTML][HTML] Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
…, KR Paulson, V Gupta, EM Abrams… - The Lancet …, 2020 - thelancet.com
Background Previous attempts to characterise the burden of chronic respiratory diseases
have focused only on specific disease conditions, such as chronic obstructive pulmonary …
have focused only on specific disease conditions, such as chronic obstructive pulmonary …
COVID-19 and the impact of social determinants of health
EM Abrams, SJ Szefler - The Lancet Respiratory Medicine, 2020 - thelancet.com
The novel coronavirus disease 2019 (COVID-19), caused by the pathogen severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), originated in Wuhan, China, and has now …
respiratory syndrome coronavirus 2 (SARS-CoV-2), originated in Wuhan, China, and has now …
The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and …
M Greenhawt, EM Abrams, M Shaker, DK Chu… - The Journal of Allergy …, 2021 - Elsevier
Concerns for anaphylaxis may hamper severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
immunization efforts. We convened a multidisciplinary group of international …
immunization efforts. We convened a multidisciplinary group of international …
Risk communication during COVID-19
EM Abrams, M Greenhawt - The Journal of Allergy and Clinical …, 2020 - Elsevier
During the unprecedented times caused by the novel coronavirus disease 2019, there is
rapidly evolving information and guidance. However, a focus must also be on proper and …
rapidly evolving information and guidance. However, a focus must also be on proper and …
Food allergy across the globe
… Author links open overlay panel Vanitha Sampath PhD a b , Elissa M. Abrams MD, MPH c
d , Bahman Adlou MS a b , Cezmi Akdis MD e , Mübeccel Akdis MD, PhD e , Helen A. Brough …
d , Bahman Adlou MS a b , Cezmi Akdis MD e , Mübeccel Akdis MD, PhD e , Helen A. Brough …
A consensus approach to the primary prevention of food allergy through nutrition: guidance from the American Academy of Allergy, Asthma, and Immunology; …
…, EM Abrams, D Stukus, M Groetch, M Shaker… - The Journal of Allergy …, 2021 - Elsevier
Recently published data from high-impact randomized controlled trials indicate the strong
potential of strategies to prevent the development of food allergy in high-risk individuals, but …
potential of strategies to prevent the development of food allergy in high-risk individuals, but …
Asthma guidelines: the Global Initiative for Asthma in relation to national guidelines
AB Becker, EM Abrams - Current opinion in allergy and clinical …, 2017 - journals.lww.com
Both GINA and national guidelines have furthered asthma care to narrow the care gap from
what is known to how asthma care is delivered, hopefully in a more directed, personalized …
what is known to how asthma care is delivered, hopefully in a more directed, personalized …
Managing asthma during coronavirus disease-2019: an example for other chronic conditions in children and adolescents
EM Abrams, SJ Szefler - The Journal of pediatrics, 2020 - jpeds.com
Elissa M. Abrams, MD, MPH1, 2, and Stanley J. Szefler, MD3, 4 The novel coronavirus
disease-2019 (COVID-19), caused by the pathogen severe acute respiratory syndrome corona …
disease-2019 (COVID-19), caused by the pathogen severe acute respiratory syndrome corona …
[HTML][HTML] CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy
…, EM Abrams, M Ben-Shoshan… - Allergy, Asthma & …, 2020 - Springer
Background Oral immunotherapy (OIT) is an emerging approach to the treatment of patients
with IgE-mediated food allergy and is in the process of transitioning to clinical practice. …
with IgE-mediated food allergy and is in the process of transitioning to clinical practice. …
